Evaluation of Thailand national external quality assessment on HIV testing
Purpose - The Thailand National Institute of Health (NIH) established an external quality assessment (EQA) scheme on HIV serology testing since 1994 for many public health laboratories. For the past six years, the NIH has evaluated the activities of 226 laboratories.Design methodology approach - App...
Gespeichert in:
Veröffentlicht in: | International journal of health care quality assurance 2007-01, Vol.20 (2), p.130-140 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 140 |
---|---|
container_issue | 2 |
container_start_page | 130 |
container_title | International journal of health care quality assurance |
container_volume | 20 |
creator | Chalermchan, Wilai Pitak, Sirporn Sungkawasee, Suwanee |
description | Purpose - The Thailand National Institute of Health (NIH) established an external quality assessment (EQA) scheme on HIV serology testing since 1994 for many public health laboratories. For the past six years, the NIH has evaluated the activities of 226 laboratories.Design methodology approach - Approximately 40,000 tests using 16 trial samples of external quality assessment panel performed at 226 laboratories during 2000-2006. The methods performed were classified into five assays; machine-based enzyme immunoassay (MBA), microplate-based enzyme immunoassay (EIA), simple rapid test and antigen assay only performed at blood screening laboratory centers. A few laboratories performed confirmation method by western blot (WB). Most participating laboratories performed at least two methods.Findings - The evaluation showed that, during the six-year period, the program had an increasing response rate among all groups of laboratories: government hospital laboratories, private hospital and clinic laboratories and blood screening laboratory centers. Moreover, there were no significantly different errors found between these groups. The highest median percent of overall errors found was in antigen assay. Very minimal errors appeared on other methods.Originality value - National HIV EQA program has played an important role in improving the quality of participating laboratory performance. The participating laboratories gained a better understanding and were able to use good quality anti-HIV approved kits. Furthermore, HIV serology testing selection was varied over the past six years as microplate-based EIA was mostly used in the past but currently MBA and simple rapid test are more commonly used. The test methods were determined by test volumes and budget. In addition, sensitivity was one critical reason labs chose to use EIA. The most popular method used was simple rapid testing. Overall errors occurred with all assays but not with WB. Errors could occur with any test techniques if good quality management is not employed. |
doi_str_mv | 10.1108/09526860710731825 |
format | Article |
fullrecord | <record><control><sourceid>proquest_istex</sourceid><recordid>TN_cdi_proquest_miscellaneous_31036827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57087682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-69555b3b7a70c4a24a485d728aff355f240785a31a22bb79dff5c36ae94f48433</originalsourceid><addsrcrecordid>eNqN0ctu1TAQBmALgehp4QHYoIgFKwK-jcdZoqrQQgEJSmFnTRIbUnI5jZOqfXsczhGVKKisHNnf_DPKMPZI8OdCcPuCFyCNNRwFRyWshDtsJRBsbkDLu2y1vOcJyB22G-MZ51wpwPtsZ0FghFyxNwcX1M40NUOfDSE7-U5NS32d9b-uqM385eTH5eN8praZrjKK0cfY-X7KUs3h0Wk2-Tg1_bcH7F6gNvqH23OPfX51cLJ_mB9_eH20__I4r0DBlJsCAEpVIiGvNElN2kKN0lIICiBIzdECKUFSliUWdQhQKUO-0EFbrdQee7rJXY_D-Zx6u66JlW_T3H6Yo0NuUiN1OwTkFo2Vt0KluNKo_gMKrlIgJvjkD3g2zMtvjE7KIk0oiiVNbFA1DjGOPrj12HQ0XjnB3bJgd2PBqebxNnguO19fV2w3mkC-AU2c_OXvdxp_OIMKwekv0r19J_D9p9Ov7mPyzzbed36k9jrxRm-3rkPi_O_83yP_BOeGyNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229706192</pqid></control><display><type>article</type><title>Evaluation of Thailand national external quality assessment on HIV testing</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Emerald Journals</source><source>MEDLINE</source><creator>Chalermchan, Wilai ; Pitak, Sirporn ; Sungkawasee, Suwanee</creator><creatorcontrib>Chalermchan, Wilai ; Pitak, Sirporn ; Sungkawasee, Suwanee</creatorcontrib><description>Purpose - The Thailand National Institute of Health (NIH) established an external quality assessment (EQA) scheme on HIV serology testing since 1994 for many public health laboratories. For the past six years, the NIH has evaluated the activities of 226 laboratories.Design methodology approach - Approximately 40,000 tests using 16 trial samples of external quality assessment panel performed at 226 laboratories during 2000-2006. The methods performed were classified into five assays; machine-based enzyme immunoassay (MBA), microplate-based enzyme immunoassay (EIA), simple rapid test and antigen assay only performed at blood screening laboratory centers. A few laboratories performed confirmation method by western blot (WB). Most participating laboratories performed at least two methods.Findings - The evaluation showed that, during the six-year period, the program had an increasing response rate among all groups of laboratories: government hospital laboratories, private hospital and clinic laboratories and blood screening laboratory centers. Moreover, there were no significantly different errors found between these groups. The highest median percent of overall errors found was in antigen assay. Very minimal errors appeared on other methods.Originality value - National HIV EQA program has played an important role in improving the quality of participating laboratory performance. The participating laboratories gained a better understanding and were able to use good quality anti-HIV approved kits. Furthermore, HIV serology testing selection was varied over the past six years as microplate-based EIA was mostly used in the past but currently MBA and simple rapid test are more commonly used. The test methods were determined by test volumes and budget. In addition, sensitivity was one critical reason labs chose to use EIA. The most popular method used was simple rapid testing. Overall errors occurred with all assays but not with WB. Errors could occur with any test techniques if good quality management is not employed.</description><identifier>ISSN: 0952-6862</identifier><identifier>EISSN: 1758-6542</identifier><identifier>DOI: 10.1108/09526860710731825</identifier><identifier>PMID: 17585612</identifier><language>eng</language><publisher>England: Emerald Group Publishing Limited</publisher><subject>Antigens ; Errors ; Health administration ; Hematologic Tests ; HIV ; HIV Infections - blood ; HIV Infections - diagnosis ; Hospitals ; Human immunodeficiency virus ; Humans ; Immunologic diseases ; Immunology ; Laboratories ; Medical laboratories ; Medical tests ; Performance evaluation ; Program Evaluation ; Public health ; Quality assessment ; Quality Assurance, Health Care ; Quality of service ; Regions ; Research methodology ; Response rates ; Serology ; Statistical analysis ; Surveys and Questionnaires ; Testing ; Tests and testing ; Thailand</subject><ispartof>International journal of health care quality assurance, 2007-01, Vol.20 (2), p.130-140</ispartof><rights>Emerald Group Publishing Limited</rights><rights>Copyright Emerald Group Publishing Limited 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-69555b3b7a70c4a24a485d728aff355f240785a31a22bb79dff5c36ae94f48433</citedby><cites>FETCH-LOGICAL-c535t-69555b3b7a70c4a24a485d728aff355f240785a31a22bb79dff5c36ae94f48433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.emerald.com/insight/content/doi/10.1108/09526860710731825/full/pdf$$EPDF$$P50$$Gemerald$$H</linktopdf><linktohtml>$$Uhttps://www.emerald.com/insight/content/doi/10.1108/09526860710731825/full/html$$EHTML$$P50$$Gemerald$$H</linktohtml><link.rule.ids>314,776,780,961,11614,12825,27901,27902,30976,30977,52661,52664</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17585612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chalermchan, Wilai</creatorcontrib><creatorcontrib>Pitak, Sirporn</creatorcontrib><creatorcontrib>Sungkawasee, Suwanee</creatorcontrib><title>Evaluation of Thailand national external quality assessment on HIV testing</title><title>International journal of health care quality assurance</title><addtitle>Int J Health Care Qual Assur</addtitle><description>Purpose - The Thailand National Institute of Health (NIH) established an external quality assessment (EQA) scheme on HIV serology testing since 1994 for many public health laboratories. For the past six years, the NIH has evaluated the activities of 226 laboratories.Design methodology approach - Approximately 40,000 tests using 16 trial samples of external quality assessment panel performed at 226 laboratories during 2000-2006. The methods performed were classified into five assays; machine-based enzyme immunoassay (MBA), microplate-based enzyme immunoassay (EIA), simple rapid test and antigen assay only performed at blood screening laboratory centers. A few laboratories performed confirmation method by western blot (WB). Most participating laboratories performed at least two methods.Findings - The evaluation showed that, during the six-year period, the program had an increasing response rate among all groups of laboratories: government hospital laboratories, private hospital and clinic laboratories and blood screening laboratory centers. Moreover, there were no significantly different errors found between these groups. The highest median percent of overall errors found was in antigen assay. Very minimal errors appeared on other methods.Originality value - National HIV EQA program has played an important role in improving the quality of participating laboratory performance. The participating laboratories gained a better understanding and were able to use good quality anti-HIV approved kits. Furthermore, HIV serology testing selection was varied over the past six years as microplate-based EIA was mostly used in the past but currently MBA and simple rapid test are more commonly used. The test methods were determined by test volumes and budget. In addition, sensitivity was one critical reason labs chose to use EIA. The most popular method used was simple rapid testing. Overall errors occurred with all assays but not with WB. Errors could occur with any test techniques if good quality management is not employed.</description><subject>Antigens</subject><subject>Errors</subject><subject>Health administration</subject><subject>Hematologic Tests</subject><subject>HIV</subject><subject>HIV Infections - blood</subject><subject>HIV Infections - diagnosis</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunologic diseases</subject><subject>Immunology</subject><subject>Laboratories</subject><subject>Medical laboratories</subject><subject>Medical tests</subject><subject>Performance evaluation</subject><subject>Program Evaluation</subject><subject>Public health</subject><subject>Quality assessment</subject><subject>Quality Assurance, Health Care</subject><subject>Quality of service</subject><subject>Regions</subject><subject>Research methodology</subject><subject>Response rates</subject><subject>Serology</subject><subject>Statistical analysis</subject><subject>Surveys and Questionnaires</subject><subject>Testing</subject><subject>Tests and testing</subject><subject>Thailand</subject><issn>0952-6862</issn><issn>1758-6542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>BENPR</sourceid><recordid>eNqN0ctu1TAQBmALgehp4QHYoIgFKwK-jcdZoqrQQgEJSmFnTRIbUnI5jZOqfXsczhGVKKisHNnf_DPKMPZI8OdCcPuCFyCNNRwFRyWshDtsJRBsbkDLu2y1vOcJyB22G-MZ51wpwPtsZ0FghFyxNwcX1M40NUOfDSE7-U5NS32d9b-uqM385eTH5eN8praZrjKK0cfY-X7KUs3h0Wk2-Tg1_bcH7F6gNvqH23OPfX51cLJ_mB9_eH20__I4r0DBlJsCAEpVIiGvNElN2kKN0lIICiBIzdECKUFSliUWdQhQKUO-0EFbrdQee7rJXY_D-Zx6u66JlW_T3H6Yo0NuUiN1OwTkFo2Vt0KluNKo_gMKrlIgJvjkD3g2zMtvjE7KIk0oiiVNbFA1DjGOPrj12HQ0XjnB3bJgd2PBqebxNnguO19fV2w3mkC-AU2c_OXvdxp_OIMKwekv0r19J_D9p9Ov7mPyzzbed36k9jrxRm-3rkPi_O_83yP_BOeGyNc</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Chalermchan, Wilai</creator><creator>Pitak, Sirporn</creator><creator>Sungkawasee, Suwanee</creator><general>Emerald Group Publishing Limited</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7QJ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>ASE</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>F~G</scope><scope>HEHIP</scope><scope>K6X</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0T</scope><scope>M1P</scope><scope>M2S</scope><scope>PQBIZ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7TA</scope><scope>8FD</scope><scope>JG9</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>Evaluation of Thailand national external quality assessment on HIV testing</title><author>Chalermchan, Wilai ; Pitak, Sirporn ; Sungkawasee, Suwanee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-69555b3b7a70c4a24a485d728aff355f240785a31a22bb79dff5c36ae94f48433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antigens</topic><topic>Errors</topic><topic>Health administration</topic><topic>Hematologic Tests</topic><topic>HIV</topic><topic>HIV Infections - blood</topic><topic>HIV Infections - diagnosis</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunologic diseases</topic><topic>Immunology</topic><topic>Laboratories</topic><topic>Medical laboratories</topic><topic>Medical tests</topic><topic>Performance evaluation</topic><topic>Program Evaluation</topic><topic>Public health</topic><topic>Quality assessment</topic><topic>Quality Assurance, Health Care</topic><topic>Quality of service</topic><topic>Regions</topic><topic>Research methodology</topic><topic>Response rates</topic><topic>Serology</topic><topic>Statistical analysis</topic><topic>Surveys and Questionnaires</topic><topic>Testing</topic><topic>Tests and testing</topic><topic>Thailand</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chalermchan, Wilai</creatorcontrib><creatorcontrib>Pitak, Sirporn</creatorcontrib><creatorcontrib>Sungkawasee, Suwanee</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Sociology Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Sociology Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Materials Business File</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of health care quality assurance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chalermchan, Wilai</au><au>Pitak, Sirporn</au><au>Sungkawasee, Suwanee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Thailand national external quality assessment on HIV testing</atitle><jtitle>International journal of health care quality assurance</jtitle><addtitle>Int J Health Care Qual Assur</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>20</volume><issue>2</issue><spage>130</spage><epage>140</epage><pages>130-140</pages><issn>0952-6862</issn><eissn>1758-6542</eissn><abstract>Purpose - The Thailand National Institute of Health (NIH) established an external quality assessment (EQA) scheme on HIV serology testing since 1994 for many public health laboratories. For the past six years, the NIH has evaluated the activities of 226 laboratories.Design methodology approach - Approximately 40,000 tests using 16 trial samples of external quality assessment panel performed at 226 laboratories during 2000-2006. The methods performed were classified into five assays; machine-based enzyme immunoassay (MBA), microplate-based enzyme immunoassay (EIA), simple rapid test and antigen assay only performed at blood screening laboratory centers. A few laboratories performed confirmation method by western blot (WB). Most participating laboratories performed at least two methods.Findings - The evaluation showed that, during the six-year period, the program had an increasing response rate among all groups of laboratories: government hospital laboratories, private hospital and clinic laboratories and blood screening laboratory centers. Moreover, there were no significantly different errors found between these groups. The highest median percent of overall errors found was in antigen assay. Very minimal errors appeared on other methods.Originality value - National HIV EQA program has played an important role in improving the quality of participating laboratory performance. The participating laboratories gained a better understanding and were able to use good quality anti-HIV approved kits. Furthermore, HIV serology testing selection was varied over the past six years as microplate-based EIA was mostly used in the past but currently MBA and simple rapid test are more commonly used. The test methods were determined by test volumes and budget. In addition, sensitivity was one critical reason labs chose to use EIA. The most popular method used was simple rapid testing. Overall errors occurred with all assays but not with WB. Errors could occur with any test techniques if good quality management is not employed.</abstract><cop>England</cop><pub>Emerald Group Publishing Limited</pub><pmid>17585612</pmid><doi>10.1108/09526860710731825</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0952-6862 |
ispartof | International journal of health care quality assurance, 2007-01, Vol.20 (2), p.130-140 |
issn | 0952-6862 1758-6542 |
language | eng |
recordid | cdi_proquest_miscellaneous_31036827 |
source | Applied Social Sciences Index & Abstracts (ASSIA); Emerald Journals; MEDLINE |
subjects | Antigens Errors Health administration Hematologic Tests HIV HIV Infections - blood HIV Infections - diagnosis Hospitals Human immunodeficiency virus Humans Immunologic diseases Immunology Laboratories Medical laboratories Medical tests Performance evaluation Program Evaluation Public health Quality assessment Quality Assurance, Health Care Quality of service Regions Research methodology Response rates Serology Statistical analysis Surveys and Questionnaires Testing Tests and testing Thailand |
title | Evaluation of Thailand national external quality assessment on HIV testing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T03%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_istex&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Thailand%20national%20external%20quality%20assessment%20on%20HIV%20testing&rft.jtitle=International%20journal%20of%20health%20care%20quality%20assurance&rft.au=Chalermchan,%20Wilai&rft.date=2007-01-01&rft.volume=20&rft.issue=2&rft.spage=130&rft.epage=140&rft.pages=130-140&rft.issn=0952-6862&rft.eissn=1758-6542&rft_id=info:doi/10.1108/09526860710731825&rft_dat=%3Cproquest_istex%3E57087682%3C/proquest_istex%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229706192&rft_id=info:pmid/17585612&rfr_iscdi=true |